{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T03:09:19Z","timestamp":1648955359311},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12098-011-0388-y","type":"journal-article","created":{"date-parts":[[2011,3,14]],"date-time":"2011-03-14T05:35:42Z","timestamp":1300080942000},"page":"1281-1283","source":"Crossref","is-referenced-by-count":0,"title":["Fundal Changes in Children Receiving Vigabatrin"],"prefix":"10.1007","volume":"78","author":[{"given":"Devendra","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheffali","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"388_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1059-1311(03)00082-7","volume":"13","author":"EJ Hilton","year":"2004","unstructured":"Hilton EJ, Hosking SL, Betts T. The effect of antiepileptic drugs on visual performance. Seizure. 2004;13:113\u201328.","journal-title":"Seizure"},{"key":"388_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pediatrneurol.2007.03.001","volume":"36","author":"A Verrotti","year":"2007","unstructured":"Verrotti A, Manco R, Matricardi S, Franzoni E, Chiarelli F. Antiepileptic drugs and visual function. Pediatr Neurol. 2007;36:353\u201360.","journal-title":"Pediatr Neurol"},{"key":"388_CR3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1528-1167.2006.00422.x","volume":"47","author":"P Kinirons","year":"2006","unstructured":"Kinirons P, Cavalleri GL, O\u2019Rourke D, et al. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose. Epilepsia. 2006;47:311\u20137.","journal-title":"Epilepsia"},{"key":"388_CR4","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.53.5.922","volume":"53","author":"R K\u00e4lvi\u00e4inen","year":"1999","unstructured":"K\u00e4lvi\u00e4inen R, Nousiainen I, M\u00e4ntyj\u00e4rvi M, et al. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. Neurology. 1999;53:922\u20136.","journal-title":"Neurology"},{"key":"388_CR5","unstructured":"The Royal College of Ophthalmologists. The ocular side-effects of vigabatrin (Sabril): information and guidance for screening. Scientific Department, The Royal College of Ophthalmologists; London: March 2008."},{"key":"388_CR6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ophtha.2004.03.036","volume":"111","author":"JR Buncic","year":"2004","unstructured":"Buncic JR, Westall CA, Panton CM, et al. Characteristic retinal atrophy with secondary \u201cinverse\u201d optic atrophy identifies vigabatrin toxicity in children. Ophthalmology. 2004;111:1935\u201342.","journal-title":"Ophthalmology"},{"key":"388_CR7","first-page":"233","volume":"316","author":"R Mackenzie","year":"1998","unstructured":"Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ. 1998;316:233.","journal-title":"BMJ"},{"key":"388_CR8","first-page":"1","volume":"7","author":"MC Lawden","year":"2006","unstructured":"Lawden MC. Vigabatrin-associated visual field constriction: a review. Optom Pract. 2006;7:1\u201314.","journal-title":"Optom Pract"},{"key":"388_CR9","first-page":"262","volume":"42","author":"P Hardus","year":"2001","unstructured":"Hardus P, Verduin WM, Engelsman M, et al. Visual field loss associated with vigabatrin: quantification and relation to dosage. Epilepsia. 2001;42:262\u20137.","journal-title":"Epilepsia"},{"key":"388_CR10","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s12098-007-0025-y","volume":"74","author":"D Mishra","year":"2007","unstructured":"Mishra D. Parents\u2019 perceptions and lifestyle issues in epilepsy. Indian J Pediatr. 2007;74:S43\u20136.","journal-title":"Indian J Pediatr"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-011-0388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-011-0388-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-011-0388-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:57:06Z","timestamp":1559447826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-011-0388-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1007\/s12098-011-0388-y","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}